This bill aims to advance research, promote awareness, and improve healthcare for thyroid disease. It directs the Secretary of Health and Human Services to conduct or support comprehensive research into the root causes, improved diagnostics, and treatments for thyroid disease, including thyroid cancer care and survivorship. A significant focus is placed on investigating disparities in prevalence, detection, treatment, and outcomes across various demographic groups, such as by race, ethnicity, and gender identity , and understanding the effects of subclinical hypothyroidism. The legislation further mandates an analysis of research gaps and the disproportionate impacts of thyroid disease on specific populations, particularly women, and the reasons behind these disparities, including access to specialized care. The Secretary will formulate recommendations for better diagnosis, treatment, and payment options, utilizing data from various health programs and surveys. These research and analysis efforts, authorized with substantial appropriations, require interim and final reports to Congress. Finally, the bill establishes a public awareness campaign to educate both the public and healthcare providers about thyroid disease. This campaign will disseminate information on incidence, treatment options, symptom recognition, and the potential benefits of routine screening, especially during pregnancy. It also aims to enhance evidence-based care, improve patient communication, and prevent implicit bias in treatment, emphasizing collaboration with professional societies and relevant HHS agencies.